Zucapsaicin
 | |
| Clinical data | |
|---|---|
| Trade names | Civanex |
| Synonyms | Civamide; (Z)-Capsaicin; cis-Capsaicin |
| Routes of administration | Topical |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ECHA InfoCard | 100.164.527 |
| Chemical and physical data | |
| Formula | C18H27NO3 |
| Molar mass | 305.41188 g/mol |
| 3D model (JSmol) | |
| |
| |
Zucapsaicin (Civanex) is a medication used to treat osteoarthritis of the knee and other neuropathic pain. It is applied three times daily for a maximum of three months. It reduces pain, and improves articular functions. It is the cis-isomer of capsaicin. Civamide, manufactured by Winston Pharmaceuticals, is produced in formulations for oral, nasal, and topical use (patch and cream).[1]
Zucapsaicin has been tested for treatment of a variety of conditions associated with ongoing nerve pain. This includes herpes simplex infections; cluster headaches and migraine; and knee osteoarthritis.[2]
References
- ↑ Winston Pharmaceuticals website "Archived copy". Archived from the original on April 25, 2012. Retrieved November 16, 2011.
- ↑ Zucapsaicin information from the National Library of Medicine http://druginfo.nlm.nih.gov/drugportal
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.